Briefing Chat: New narcolepsy drug could unlock host of novel brain therapies

TL;DR - Nature staff discuss an FDA-approved narcolepsy drug that might enable therapies for other brain disorders, alongside research on the longest-lived human brain organoids reported to date. The supplied summary does not provide drug mechanisms, efficacy data, or organoid longevity details.

• The narcolepsy drug’s regulatory approval could accelerate investigation of uses beyond its original indication.
• Long-lived human brain organoids may support longer-term studies of brain development and disease.
• The content provided is a briefing overview, so no specific experimental results or clinical outcomes can be inferred.